antifungal therapy

Known as: Treatment of Fungal Infectious Disease, therapy, antifungal 
Drug treatment to destroy or inhibit the growth or multiplication of fungi.
National Institutes of Health

Related topics

Related topics

2 relations
Antibiotic therapyinfection prophylaxis/management

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.
This analysis describes the epidemiology and outcomes of candidemia in patients enrolled in the Prospective Antifungal Therapy… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
In 2005, several groups, including the European Group for Blood and Marrow Transplantation, the European Organization for… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
BACKGROUND Empirical antifungal therapy is the standard of care for neutropenic patients with hematological malignancies who… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
BACKGROUND Empirical antifungal therapy is the standard treatment for persistent or relapsing antibiotic-resistant neutropenic… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
Review
2004
Review
2004
Combination antifungal therapy.
Combination Antifungal Therapy Melissa D. Johnson,* Conan MacDougall, Luis Ostrosky-Zeichner, John R. Perfect, and John H. Rex… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
BACKGROUND Patients with persistent fever and neutropenia often receive empirical therapy with conventional or liposomal… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
BACKGROUND Invasive aspergillosis (IA) is an important cause of morbidity and mortality among immunocompromised patients… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
BACKGROUND Patients with neutropenia and persistent fever are often treated empirically with amphotericin B or liposomal… (More)
  • table 3
  • figure 1
  • table 5
Is this relevant?
Review
1994
Review
1994
Oral azole drugs as systemic antifungal therapy.
The oral azole drugs--ketoconazole, fluconazole, and itraconazole--represent a major advance in systemic antifungal therapy… (More)
Is this relevant?
Highly Cited
1976
Highly Cited
1976
Combination antifungal therapy for cryptococcal meningitis.
In classical pernicious anaemia the histological appearances are characteristic and the gastric antrum is not involved (Magnus… (More)
  • figure 1
Is this relevant?